David Zeferino D'Azevedo Cristina
Amministratore Delegato presso Acellera Therapeutics Lda.
Posizioni attive di David Zeferino D'Azevedo Cristina
Società | Posizione | Inizio | Fine |
---|---|---|---|
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Amministratore Delegato | 01/07/2010 | - |
Fondatore | 01/07/2010 | - | |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di David Zeferino D'Azevedo Cristina
Precedenti posizioni note di David Zeferino D'Azevedo Cristina
Società | Posizione | Inizio | Fine |
---|---|---|---|
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Consulente / Consigliere | 01/03/2015 | 31/10/2017 |
Statistiche
Distribuzione geografica
Portogallo | 4 |
Posizioni
Chief Executive Officer | 1 |
Founder | 1 |
Consultant / Advisor | 1 |
Settori
Health Technology | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Acellera Therapeutics Lda.
Acellera Therapeutics Lda. BiotechnologyHealth Technology Acellera Therapeutics Lda. engages in the development of platform technology for immunessupression to treat immune-mediated diseases. The company is headquartered in Lisbon, Portugal. | Health Technology |
Portugal Capital Ventures SCR SA
Portugal Capital Ventures SCR SA Investment ManagersFinance Portugal Capital Ventures SCR SA (Portugal Capital) is a venture capital firm founded in 1989. The firm is headquartered in Porto, Portugal. | Finance |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |